Getein Biotech, Inc — Investor Relations & Filings

Getein Biotech, Inc. specializes in the research, development, manufacturing, and distribution of in vitro diagnostic reagents and instruments. The company provides a diverse portfolio of diagnostic solutions across multiple technology platforms, including Point-of-Care Testing (POCT), chemiluminescence immunoassay (CLIA), clinical chemistry, hematology, and molecular diagnostics. Its product offerings address various clinical fields such as cardiovascular health, inflammatory markers, infectious diseases, diabetes management, renal function, and fertility. Getein focuses on delivering rapid, accurate, and reliable diagnostic tools to healthcare facilities and laboratories. By leveraging integrated research and production capabilities, the company develops high-sensitivity assays and automated analytical systems designed to enhance clinical decision-making and improve patient care outcomes through efficient diagnostic workflows.